Search

Your search keyword '"Hellemons, M.E."' showing total 19 results
Start Over Author "Hellemons, M.E."
19 results on '"Hellemons, M.E."'

1. WS01.03 Effects of elexacaftor/tezacaftor/ivacaftor in lung transplant recipients with cystic fibrosis: the Dutch national KOALA study

Author

van Gemert, J.P., primary, Luijk, B., additional, Hellemons, M.E., additional, Visser, K.A., additional, Hansen, C., additional, Meer, R. van der, additional, Gan, T., additional, Vaart, H. van der, additional, Akkerman, O.W., additional, Steenhuis, W.N., additional, Verkleij, M., additional, Heijerman, H.G.M., additional, and Verschuuren, E.A.M., additional

Published
2024
Full Text
View/download PDF

4. Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.

Author

Jong, C.M.M. de, Visser, Chantal, Bemelmans, R.H.H., Boersma, W.G., Borst, B. van den, Burggraaf, J.L., Cannegieter, S.C., Cate-Hoek, A.J. Ten, Croles, F.N., Faber, H.J., Faber, L.M., Hellemons, M.E., Hessels, L.M., Huisman, M.V., Kamphuisen, P.W., Koster, S.C.E., Kroft, L.J., Lee, I. van der, Leentjens, J., Meijer, K, Ninaber, M.K., Sondermeijer, B.M., Stads, S., Vonk Noordegraaf, A., Winckers, K., Kruip, M.J.H.A., Klok, F.A., Jong, C.M.M. de, Visser, Chantal, Bemelmans, R.H.H., Boersma, W.G., Borst, B. van den, Burggraaf, J.L., Cannegieter, S.C., Cate-Hoek, A.J. Ten, Croles, F.N., Faber, H.J., Faber, L.M., Hellemons, M.E., Hessels, L.M., Huisman, M.V., Kamphuisen, P.W., Koster, S.C.E., Kroft, L.J., Lee, I. van der, Leentjens, J., Meijer, K, Ninaber, M.K., Sondermeijer, B.M., Stads, S., Vonk Noordegraaf, A., Winckers, K., Kruip, M.J.H.A., and Klok, F.A.

Abstract

01 april 2023, Item does not contain fulltext, The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE https://bit.ly/3IjvWL3

Published
2023

10. TTV Load is Associated with SARS-CoV-2 Vaccination Response in Lung Transplant Recipients

Author

Verschuuren, E.A., primary, Hoek, R., additional, de Vries, R.D., additional, van Baarle, D., additional, van der Heiden, M., additional, van Gemert, J., additional, Gore, E., additional, Niesters, H.G., additional, Erasmus, M.E., additional, Hellemons, M.E., additional, Scherbeijn, S., additional, van Kessel, C.H. Geurts, additional, and van Leer Buter, C., additional

Published
2022
Full Text
View/download PDF

15. Evaluation of a home monitoring application for follow up after lung transplantation—a pilot study

Author

Wijbenga, N. (Nynke), Hoek, R.A.S. (Rogier), Mathot, B.J., Seghers, L. (Leonard), van Weezel, J.J. (Jan J.), Ouden, J.D. (José Den), Wijsenbeek-Lourens, M.S. (Marlies), Aerts, J.G.J.V. (Joachim), Hellemons, M.E. (Merel E.), Moor, C.C. (Karen), Wijbenga, N. (Nynke), Hoek, R.A.S. (Rogier), Mathot, B.J., Seghers, L. (Leonard), van Weezel, J.J. (Jan J.), Ouden, J.D. (José Den), Wijsenbeek-Lourens, M.S. (Marlies), Aerts, J.G.J.V. (Joachim), Hellemons, M.E. (Merel E.), and Moor, C.C. (Karen)

Abstract

Home spirometry after lung transplantation is common practice, to monitor graft function. However, there is little experience with online home monitoring applications with direct data transfer to the hospital. We evaluated the feasibility and patient experiences with a new online home monitoring application, integrated with a Bluetooth-enabled spirometer and real-time data transfer. Consecutive lung transplant recipients were asked to evaluate this home monitoring application for three months in a pilot study. Home spirometry measurements were compared with in-hospital lung function tests (the forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC)) at the end of the study. Ten patients participated. The home and hospital spirometry measurements showed a high correlation, for both the FEV1 (r = 0.99, p < 0.01) and FVC (r = 0.99, p < 0.01). The adherence and patient satisfaction were high, and the patients preferred the home monitoring application over the current home spirometer, with a difference of 1.4 ± 1.5 points on a scale from 0 to 10 (p = 0.02). Online home monitoring with direct data transfer is feasible and reliable after lung transplantation and results in high patient satisfaction. Whether the implementation of online home monitoring enables the earlier detection of lung function decline and improves patient and graft outcomes will be the subject of future research.

Published
2020
Full Text
View/download PDF

16. Desquamative interstitial pneumonia: A systematic review of its features and outcomes

Author

Hellemons, M.E. (Merel E.), Moor, C.C. (Karen), Thüsen, J.V. (Jan von der), Rossius, M. (Mariska), Odink, A.E. (Arlette), Thorgersen, L.H. (Laila Haugen), Verschakelen, J. (Johny), Wuyts, W.A. (Wim A.), Wijsenbeek-Lourens, M.S. (Marlies), Bendstrup, E. (Elisabeth), Hellemons, M.E. (Merel E.), Moor, C.C. (Karen), Thüsen, J.V. (Jan von der), Rossius, M. (Mariska), Odink, A.E. (Arlette), Thorgersen, L.H. (Laila Haugen), Verschakelen, J. (Johny), Wuyts, W.A. (Wim A.), Wijsenbeek-Lourens, M.S. (Marlies), and Bendstrup, E. (Elisabeth)

Abstract

Background: Desquamative Interstitial Pneumonia (DIP) is a rare form of idiopathic interstitial pneumonia (IIP). Data on clinical features, aetiology, prognosis and effect of treatment strategies are limited. We aimed to collect all published cases to better characterise DIP. Methods: A systematic literature search was performed for all original cases of adult patients with histopathologically-confirmed DIP. Individual patient data were extracted and summarised. Results: We included 68 individual cases and 13 case series reporting on 294 cases. Most common presenting symptoms were dyspnoea and cough. Pulmonary function showed a restrictive pattern (71%) with decreased diffusion capacity. We found a high incidence (81%) of ever smoking in patients with DIP and 22% of patients had other (occupational) exposures. Characteristic features on high-resolution computed tomography (HRCT) scan were bilateral ground-glass opacities with lower lobe predominance (92%). Treatment and duration of treatment widely varied. Initial response to treatment was generally good, but definitely not uniformly so. A significant proportion of patients died (25% of individual cases) or experienced a relapse (18% of individual cases). Conclusion: DIP remains an uncommon disease, frequently but not always related to smoking or other exposures. Furthermore, DIP behaves as a progressive disease more often than generally thought, possibly associated with different underlying aetiology.

Published
2020
Full Text
View/download PDF

17. Developments in lung transplantation over the past decade

Author

van der Mark, S.C. (Sophie C.), Hoek, R.A.S. (Rogier), Hellemons, M.E. (Merel E.), van der Mark, S.C. (Sophie C.), Hoek, R.A.S. (Rogier), and Hellemons, M.E. (Merel E.)

Abstract

With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, improvement of quality of life is achieved in the vast majority of patients. Many developments have taken place in the field of lung transplantation over the past decade. Broadened indication criteria and bridging techniques for patients awaiting lung transplantation have led to increased waiting lists and changes in allocation schemes worldwide. Moreover, the use of previously unacceptable donor lungs for lung transplantation has increased, with donations from donors after cardiac death, donors with increasing age and donors with positive smoking status extending the donor pool substantially. Use of ex vivo lung perfusion further increased the number of lungs suitable for lung transplantation. Nonetheless, the use of these previously unacceptable lungs did not have detrimental effects on survival and long-term graft outcomes, and has decreased waiting list mortality. To further improve long-term outcomes, strategies have been proposed to modify chronic lung allograft dysfunction progression and minimise toxic immunosuppressive effects. This review summarises the developments in clinical lung transplantation over the past decade.

Published
2020
Full Text
View/download PDF

19. Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019

Author

Armocida, Benedetta, Monasta, Lorenzo, Sawyer, Susan, Bustreo, Flavia, Segafredo, Giulia, Castelpietra, Giulio, Ronfani, Luca, Pasovic, Maja, Hay, Simon, Perel, Pablo, Beran, David, Sawyer, Susan M., Hay, Simon I., Abila, Derrick Bary, Abolhassani, Hassan, Accrombessi, Manfred Mario Kokou, Adekanmbi, Victor, Ahmadi, Keivan, Al Hamad, Hanadi, Aldeyab, Mamoon A., Al-Jumaily, Adel, Ancuceanu, Robert, Andrei, Catalina Liliana, Andrei, Tudorel, Arumugam, Ashokan, Attia, Sameh, Aujayeb, Avinash, Ausloos, Marcel, Baker, Jennifer L., Barone-Adesi, Francesco, Barra, Fabio, Barteit, Sandra, Basu, Sanjay, Baune, Bernhard T., Béjot, Yannick, Belo, Luis, Bennett, Derrick A., Bikbov, Boris, Bikov, Andras, Blyuss, Oleg, Breitner, Susanne, Brenner, Hermann, Carreras, Giulia, Carvalho, Márcia, Catapano, Alberico L., Chandan, Joht Singh, Charalampous, Periklis, Chen, Simiao, Conde, Joao, Cruz-Martins, Natália, Damiani, Giovanni, Dastiridou, Anna, de la Torre-Luque, Alejandro, Dianatinasab, Mostafa, Dias da Silva, Diana, Douiri, Abdel, Dragioti, Elena, Engelbert Bain, Luchuo, Fagbamigbe, Adeniyi Francis, Fereshtehnejad, Seyed-Mohammad, Ferrara, Pietro, Ferreira de Oliveira, José Miguel P., Ferrero, Simone, Ferro Desideri, Lorenzo, Fischer, Florian, Fonseca, Diogo, Gaewkhiew, Piyada, Gaihre, Santosh, Gallus, Silvano, Gaspar Fonseca, Mariana, Gill, Paramjit, Glasbey, James C., Gorini, Giuseppe, Gupta, Vijai Kumar, Gurara, Mekdes Kondale, Haro, Josep Maria, Hasan, M Tasdik, Havmoeller, Rasmus J., Heibati, Behzad, Hellemons, Merel E., Herteliu, Claudiu, Hussain, Salman, Isola, Gaetano, Johnson, Olatunji, Jonas, Jost B., Jozwiak, Jacek Jerzy, Jürisson, Mikk, Kabir, Zubair, Karch, André, Kauppila, Joonas H., Kayode, Gbenga A., Khan, Moien A. B., Khatab, Khaled, Kivimäki, Mika, Klugar, Miloslav, Klugarová, Jitka, Koly, Kamrun Nahar, Koyanagi, Ai, Kurmi, Om P., Kusuma, Dian, La Vecchia, Carlo, Lacey, Ben, Lallukka, Tea, Lamnisos, Demetris, Langguth, Berthold, Larsson, Anders O., Lauriola, Paolo, Lee, Paul H., Leonardi, Matilde, Li, An, Linehan, Christine, López-Bueno, Rubén, Lorkowski, Stefan, Loureiro, Joana A., Lunevicius, Raimundas, Magee, Laura A., Magnani, Francesca Giulia, Majeed, Azeem, Makris, Konstantinos Christos, Mathioudakis, Alexander G., Mathur, Manu Raj, McGrath, John J., Menezes, Ritesh G., Mentis, Alexios-Fotios A., Meretoja, Atte, Mestrovic, Tomislav, Miao Jonasson, Junmei, Miazgowski, Tomasz, Mirica, Andreea, Moccia, Marcello, Mohammed, Shafiu, Molokhia, Mariam, Mondello, Stefania, Mueller, Ulrich Otto, Mulita, Francesk, Munblit, Daniel, Negoi, Ionut, Negoi, Ruxandra Irina, Nena, Evangelia, Noor, Nurulamin M., Nowak, Christoph, Ntaios, George, Nwatah, Vincent Ebuka, Oancea, Bogdan, Oguntade, Ayodipupo Sikiru, Ortiz, Alberto, Otoiu, Adrian, Padron-Monedero, Alicia, Palladino, Raffaele, Pana, Adrian, Panagiotakos, Demosthenes, Panda-Jonas, Songhomitra, Pardhan, Shahina, Patel, Jay, Pedersini, Paolo, Peñalvo, José L., Pensato, Umberto, Pereira, Renato B., Perico, Norberto, Petcu, Ionela-Roxana, Polinder, Suzanne, Postma, Maarten J., Rabiee, Mohammad, Rabiee, Navid, Raggi, Alberto, Rahimzadeh, Shadi, Rawaf, David Laith, Rawaf, Salman, Rehman, Faizan Ur, Remuzzi, Giuseppe, Riad, Abanoub, Rodriguez, Alina, Sacco, Simona, Saeb, Mohammad Reza, Safdarian, Mahdi, Sathian, Brijesh, Sattin, Davide, Saxena, Sonia, Scarmeas, Nikolaos, Schlee, Winfried, Schwendicke, Falk, Shamsizadeh, Morteza, Sharew, Nigussie Tadesse, Shiri, Rahman, Shivalli, Siddharudha, Shivarov, Velizar, Silva, João Pedro, Simpson, Colin R., Skou, Søren T., Socea, Bogdan, Soyiri, Ireneous N., Steiropoulos, Paschalis, Straif, Kurt, Sun, Xiaohui, Tabarés-Seisdedos, Rafael, Thiyagarajan, Arulmani, Topouzis, Fotis, Tovani-Palone, Marcos Roberto, Truelsen, Thomas Clement, Unim, Brigid, Van den Eynde, Jef, Vasankari, Tommi Juhani, Veroux, Massimiliano, Villafaina, Santos, Vinko, Matej, Violante, Francesco S., Volovici, Victor, Wang, Yanzhong, Westerman, Ronny, Yadegarfar, Mohammad Esmaeil, Yaya, Sanni, Zadnik, Vesna, Zumla, Alimuddin, HASH(0x5651c96cd260), Bill & Melinda Gates Foundation, Public Health, Pulmonary Medicine, Neurosurgery, Collaborators, GBD 2019 Europe NCDs in Adolescents, Lacey, BWH, Yaya, S, HUS Neurocenter, Department of Neurosciences, Armocida B., Monasta L., Sawyer S., Bustreo F., Segafredo G., Castelpietra G., Ronfani L., Pasovic M., Hay S., Sawyer S.M., Hay S.I., Abila D.B., Abolhassani H., Accrombessi M.M.K., Adekanmbi V., Ahmadi K., Al Hamad H., Aldeyab M.A., Al-Jumaily A., Ancuceanu R., Andrei C.L., Andrei T., Arumugam A., Attia S., Aujayeb A., Ausloos M., Baker J.L., Barone-Adesi F., Barra F., Barteit S., Basu S., Baune B.T., Bejot Y., Belo L., Bennett D.A., Bikbov B., Bikov A., Blyuss O., Breitner S., Brenner H., Carreras G., Carvalho M., Catapano A.L., Chandan J.S., Charalampous P., Chen S., Conde J., Cruz-Martins N., Damiani G., Dastiridou A., de la Torre-Luque A., Dianatinasab M., Dias da Silva D., Douiri A., Dragioti E., Engelbert Bain L., Fagbamigbe A.F., Fereshtehnejad S.-M., Ferrara P., Ferreira de Oliveira J.M.P., Ferrero S., Ferro Desideri L., Fischer F., Fonseca D.A., Gaewkhiew P., Gaihre S., Gallus S., Gaspar Fonseca M., Gill P.S., Glasbey J.C., Gorini G., Gupta V.K., Gurara M.K., Haro J.M., Hasan M.T., Havmoeller R.J., Heibati B., Hellemons M.E., Herteliu C., Hussain S., Isola G., Johnson O., Jonas J.B., Jozwiak J.J., Jurisson M., Kabir Z., Karch A., Kauppila J.H., Kayode G.A., Khan M.A., Khatab K., Kivimaki M., Klugar M., Klugarova J., Koly K.N., Koyanagi A., Kurmi O.P., Kusuma D., La Vecchia C., Lacey B., Lallukka T., Lamnisos D., Langguth B., Larsson A.O., Lauriola P., Lee P.H., Leonardi M., Li A., Linehan C., Lopez-Bueno R., Lorkowski S., Loureiro J.A., Lunevicius R., Magee L.A., Magnani F.G., Majeed A., Makris K.C., Mathioudakis A.G., Mathur M.R., McGrath J.J., Menezes R.G., Mentis A.-F.A., Meretoja A., Mestrovic T., Miao Jonasson J., Miazgowski T., Mirica A., Moccia M., Mohammed S., Molokhia M., Mondello S., Mueller U.O., Mulita F., Munblit D., Negoi I., Negoi R.I., Nena E., Noor N.M., Nowak C., Ntaios G., Nwatah V.E., Oancea B., Oguntade A.S., Ortiz A., Otoiu A., Padron-Monedero A., Palladino R., Pana A., Panagiotakos D., Panda-Jonas S., Pardhan S., Patel J., Pedersini P., Penalvo J.L., Pensato U., Pereira R.B., Perico N., Petcu I.-R., Polinder S., Postma M.J., Rabiee M., Rabiee N., Raggi A., Rahimzadeh S., Rawaf D.L., Rawaf S., Rehman F.U., Remuzzi G., Riad A., Rodriguez A., Sacco S., Saeb M.R., Safdarian M., Sathian B., Sattin D., Saxena S., Scarmeas N., Schlee W., Schwendicke F., Shamsizadeh M., Sharew N.T., Shiri R., Shivalli S., Shivarov V., Silva J.P., Simpson C.R., Skou S.T., Socea B., Soyiri I.N., Steiropoulos P., Straif K., Sun X., Tabares-Seisdedos R., Thiyagarajan A., Topouzis F., Tovani-Palone M.R., Truelsen T.C., Unim B., Van den Eynde J., Vasankari T.J., Veroux M., Villafaina S., Vinko M., Violante F.S., Volovici V., Wang Y., Westerman R., Yadegarfar M.E., Yaya S., Zadnik V., Zumla A., Perel P., Beran D., Armocida, B, Monasta, L, Sawyer, S, Ferrara, P, Benedetta, Armocida, Lorenzo, Monasta, Susan, Sawyer, Flavia, Bustreo, Giulia, Segafredo, Giulio, Castelpietra, Luca, Ronfani, Maja, Pasovic, Simon, Hay, Pablo, Perel, David, Beran, Bary Abila, Derrick, Abolhassani, Hassan, Adekanmbi, Victor, Al Hamad, Hanadi, Armocida, Benedetta, Attia, Sameh, Ausloos, Marcel, L Baker, Jennifer, Barteit, Sandra, Basu, Sanjay, Beran, David, Bikbov, Bori, Damiani, Giovanni, de la Torre-Luque, Alejandro, Dianatinasab, Mostafa, Dias da Silva, Diana, Douiri, Abdel, Dragioti, Elena, Engelbert Bain, Luchuo, Gaihre, Santosh, C Glasbey, Jame, Kumar Gupta, Vijai, Maria Haro, Josep, Herteliu, Claudiu, Isola, Gaetano, B Jonas, Jost, Jerzy Jozwiak, Jacek, Jürisson, Mikk, Kabir, Zubair, Karch, André, H Kauppila, Joona, A Kayode, Gbenga, AB Khan, Moien, Khatab, Khaled, Klugarová, Jitka, Kusuma, Dian, López-Bueno, Rubén, Lorkowski, Stefan, Christos Makris, Konstantino, Raj Mathur, Manu, G Menezes, Ritesh, Meretoja, Atte, Moccia, Marcello, Mohammed, Shafiu, Molokhia, Mariam, Monasta, Lorenzo, Otto Mueller, Ulrich, Mulita, Francesk, Negoi, Ionut, Irina Negoi, Ruxandra, Oancea, Bogdan, Sikiru Oguntade, Ayodipupo, Ortiz, Alberto, Pana, Adrian, Panagiotakos, Demosthene, Panda-Jonas, Songhomitra, Pardhan, Shahina, Pasovic, Maja, Patel, Jay, L Peñalvo, José, B Pereira, Renato, Polinder, Suzanne, J Postma, Maarten, Rabiee, Mohammad, Rabiee, Navid, Laith Rawaf, David, Rawaf, Salman, Ronfani, Luca, Reza Saeb, Mohammad, Sathian, Brijesh, Saxena, Sonia, Pedro Silva, João, Tabarés-Seisdedos, Rafael, Roberto Tovani-Palone, Marco, Clement Truelsen, Thoma, Juhani Vasankari, Tommi, Villafaina, Santo, Westerman, Ronny, Yaya, Sanni, Zadnik, Vesna, Zumla., and Alimuddin, Sawyer, Susan, Bustreo, Flavia, Segafredo, Giulia, Castelpietra, Giulio, Hay, Simon, Perel, Pablo, M Sawyer, Susan, I Hay, Simon, Mario Kokou Accrombessi, Manfred, Ahmadi, Keivan, A Aldeyab, Mamoon, Al-Jumaily, Adel, Ancuceanu, Robert, Liliana Andrei, Catalina, Andrei, Tudorel, Arumugam, Ashokan, Aujayeb, Avinash, Barone-Adesi, Francesco, Barra, Fabio, T Baune, Bernhard, B??jot, Yannick, Belo, Lui, A Bennett, Derrick, Bikov, Andra, Blyuss, Oleg, Breitner, Susanne, Brenner, Hermann, Carreras, Giulia, Carvalho, M??rcia, L Catapano, Alberico, Singh Chandan, Joht, Charalampous, Perikli, Chen, Simiao, Conde, Joao, Cruz-Martins, Nat??lia, Dastiridou, Anna, Francis Fagbamigbe, Adeniyi, Fereshtehnejad, Seyed-Mohammad, Ferrara, Pietro, P Ferreira de Oliveira, Jos?? Miguel, Ferrero, Simone, Ferro Desideri, Lorenzo, Fischer, Florian, A Fonseca, Diogo, Gaewkhiew, Piyada, Gallus, Silvano, Gaspar Fonseca, Mariana, Singh Gill, Paramjit, Gorini, Giuseppe, Kondale Gurara, Mekde, Tasdik Hasan, M, J Havmoeller, Rasmu, Heibati, Behzad, E Hellemons, Merel, Hussain, Salman, Johnson, Olatunji, J??risson, Mikk, Karch, Andr??, Kivim??ki, Mika, Klugar, Miloslav, Klugarov??, Jitka, Nahar Koly, Kamrun, Koyanagi, Ai, P Kurmi, Om, La Vecchia, Carlo, Lacey, Ben, Lallukka, Tea, Lamnisos, Demetri, Langguth, Berthold, O Larsson, Ander, Lauriola, Paolo, H Lee, Paul, Leonardi, Matilde, Li, An, Linehan, Christine, L??pez-Bueno, Rub??n, A Loureiro, Joana, Lunevicius, Raimunda, A Magee, Laura, Giulia Magnani, Francesca, Majeed, Azeem, G Mathioudakis, Alexander, J McGrath, John, A Mentis, Alexios-Fotio, Mestrovic, Tomislav, Miao Jonasson, Junmei, Miazgowski, Tomasz, Mirica, Andreea, Mondello, Stefania, Munblit, Daniel, Nena, Evangelia, M Noor, Nurulamin, Nowak, Christoph, Ntaios, George, Ebuka Nwatah, Vincent, Otoiu, Adrian, Padron-Monedero, Alicia, Palladino, Raffaele, Pedersini, Paolo, L Pe??alvo, Jos??, Pensato, Umberto, Perico, Norberto, Petcu, Ionela-Roxana, Raggi, Alberto, Rahimzadeh, Shadi, Ur Rehman, Faizan, Remuzzi, Giuseppe, Riad, Abanoub, Rodriguez, Alina, Sacco, Simona, Safdarian, Mahdi, Sattin, Davide, Scarmeas, Nikolao, Schlee, Winfried, Schwendicke, Falk, Shamsizadeh, Morteza, Tadesse Sharew, Nigussie, Shiri, Rahman, Shivalli, Siddharudha, Shivarov, Velizar, Pedro Silva, Jo??o, R Simpson, Colin, T Skou, S??ren, Socea, Bogdan, N Soyiri, Ireneou, Steiropoulos, Paschali, Straif, Kurt, Sun, Xiaohui, Tabar??s-Seisdedos, Rafael, Thiyagarajan, Arulmani, Topouzis, Foti, Unim, Brigid, Van den Eynde, Jef, Veroux, Massimiliano, Vinko, Matej, S Violante, Francesco, Volovici, Victor, Wang, Yanzhong, Esmaeil Yadegarfar, Mohammad, Zumla, Alimuddin, University of St Andrews. Population and Behavioural Science Division, and University of St Andrews. School of Medicine

Subjects
Male, mortality burden, Adolescent, RJ, RJ101, Care, Global Burden of Disease, Life Expectancy, RJ101 Child Health. Child health services, SDG 3 - Good Health and Well-being, RA0421, 3123 Gynaecology and paediatrics, Risk Factors, RA0421 Public health. Hygiene. Preventive Medicine, Developmental and Educational Psychology, Humans, Disabled Persons, Noncommunicable Diseases, Future, Determinants, MCC, Disability, Public Health, Global Health, Social Medicine and Epidemiology, Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019, 3rd-DAS, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, n/a, Health, Pediatrics, Perinatology and Child Health, Female, RA
Abstract

Background:Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods:Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10–14 years, 15–19 years, and 20–24 years), and by sex. Spearman's correlation was conducted between DALY rates for NCDs and the Socio-demographic Index (SDI) of each EU Member State. Findings:In 2019, NCDs accounted for 86·4% (95% uncertainty interval 83·5–88·8) of all YLDs and 38·8% (37·4–39·8) of total deaths in adolescents aged 10–24 years. For NCDs in this age group, neoplasms were the leading causes of both mortality (4·01 [95% uncertainty interval 3·62–4·25] per 100 000 population) and YLLs (281·78 [254·25–298·92] per 100 000 population), whereas mental disorders were the leading cause for YLDs (2039·36 [1432·56–2773·47] per 100 000 population) and DALYs (2040·59 [1433·96–2774·62] per 100 000 population) in all EU Member States, and in all studied age groups. In 2019, among adolescents aged 10–24 years, males had a higher mortality rate per 100 000 population due to NCDs than females (11·66 [11·04–12·28]vs7·89 [7·53–8·23]), whereas females presented a higher DALY rate per 100 000 population due to NCDs (8003·25 [5812·78–10 701·59]vs6083·91 [4576·63–7857·92]). From 1990 to 2019, mortality rate due to NCDs in adolescents aged 10–24 years substantially decreased (–40·41% [–43·00 to –37·61), and also the YLL rate considerably decreased (–40·56% [–43·16 to –37·74]), except for mental disorders (which increased by 32·18% [1·67 to 66·49]), whereas the YLD rate increased slightly (1·44% [0·09 to 2·79]). Positive correlations were observed between DALY rates and SDIs for substance use disorders (rs=0·58, p=0·0012) and skin and subcutaneous diseases (rs=0·45, p=0·017), whereas negative correlations were found between DALY rates and SDIs for cardiovascular diseases (rs=–0·46, p=0·015), neoplasms (rs=–0·57, p=0·0015), and sense organ diseases (rs=–0·61, p=0·0005). Interpretation:NCD-related mortality has substantially declined among adolescents in the EU between 1990 and 2019, but the rising trend of YLL attributed to mental disorders and their YLD burden are concerning. Differences by sex, age group, and across EU Member States highlight the importance of preventive interventions and scaling up adolescent-responsive health-care systems, which should prioritise specific needs by sex, age, and location. Funding: Bill & Melinda Gates Foundation.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results